Advertisement

Author: Philip Davis

Tuesday – Unthinking the Euro Crisis

“It’s still absurd and unthinkable in many senses of the word for people who really understand what it means to have a monetary union, it’s really unmanageable and unthinkable. “Some people that seem to...

Read More

Sabrient Risers – 12/20/2011

Top 5 Risers Stock Rating Analysis PAY BUY Projected value continues to rise for VeriFone while long term increases in earnings growth are also becoming more widely expected. DNR BUY Denbury has shown a remarkable increase in...

Read More

What the Market Wants: Bah! Humbug!

Courtesy of Walter Gault, Communications Editor, Sabrient Bah! Humbug! By David Brown, Chief Market Strategist, Sabrient Systems The market is taking on a Dickensian atmosphere for the holidays! The S&P is down another 1.2%...

Read More

The Skinny on the Hepatitis C Market

Reminder: Pharmboy is available to chat with Members, comments are found below each post. For the past few years at Phil’s Stock World, many of my articles have focused on cancer therapies or the robust (or not so robust)...

Read More

Sabrient Risers – 12/19/2011

Top 5 Risers Stock Rating Analysis PAY BUY Projected value continues to rise for VeriFone while long term increases in earnings growth are also becoming more widely expected. DNR BUY Denbury has shown a remarkable increase in...

Read More

PSW 2011 Holiday Shopping Survey

Only 7 shopping days left! Next week is “Super Saturday” (they seem to just make this stuff up every year) but I was not overly impressed by the crowd at the Wayne Town Center Mall yesterday. We were not even...

Read More

Sabrient Risers – 12/18/2011

Top 5 Risers Stock Rating Analysis PAY BUY Projected value continues to rise for VeriFone while long term increases in earnings growth are also becoming more widely expected. DNR BUY Denbury has shown a remarkable increase in...

Read More

Sabrient Risers – 12/17/2011

Top 5 Risers Stock Rating Analysis DNR BUY Denbury has shown a remarkable increase in projected value recently, with the majority of analysts expecting higher than previously expected earnings. PAY BUY Projected value continues...

Read More

SIGN UP TO NEWSLETTER

Join our mailing list to receive the latest news and updates from our team.